19 June 2013
Keywords: Abbott, Trilipix and statins, FDA advisory, dislipedemia, Cholesterol
Article | 20 May 2011
The US Food and Drug Administration’s Endocrinologic and Metabolic Drugs Advisory Committee to review the results of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 May 2011
19 May 2011
© 2013 thepharmaletter.com